LogoAntiCirc
Back to Research Index
πŸ‡³πŸ‡¦

Namibia

Deep-built
ISO: NAM Region: Sub-Saharan Africa

25% circumcision prevalence

Prevalence of non-therapeutic male circumcision.

Research coverage

A transparent snapshot of what this file currently contains.

PrevalenceComplete
Categorical profileComplete
Circumcision by intentComplete
Deep write-upsComplete
Native perspectiveExploratory

8

Sources Β· Citations

8

Verifications Β· Independent

5

Structured claims Β· Evidence-based

Jul 9, 2026

Last updated Β· deep-built

Research note: Namibia β€” built June 2026 deep-research burst (wf_ea0c5f84-c7b): regional patchwork case. 21% (2006-07 DHS, pre-VMMC, n=3,915) β†’ 25.5% (2013 DHS; Morris 2016 corroborates unchanged after erratum). Otjozondjupa Region: 72.27% circumcision (279/386; 2017-18 cross-sectional; MEDIUM conf β€” convenience sample; 2-1 verified); 66.66% traditionally circumcised / 33.34% medical. Owambo (OvaAmbo) traditional circumcision documented (northern regions, ~50% of population; specific ongombo/ombwiti primary sources not verified β€” background knowledge MEDIUM confidence). Herero/Himba 55.56% + 'babies and small boys' claim REFUTED 1-2. '21% with one-quarter traditional' claim REFUTED 0-3. VMMC: 52,022 CDC-supported 2017-2019 (15,579/70.1%, 19,384/82.7%, 17,059/73.3%); CDC transition to other US agency beginning 2020 β†’ 0 CDC-reported 2020-2021 (programme continuity gap). Priority: Khomas + Zambezi. AEs: 1.7% (498/28,990; Oshana+Zambezi 2015-2018); 77% moderate/23% severe; infections+wound disruption 80%; bleeding early (≀day 2) / infections late (>day 7). HARM: HONEST GAP β€” 0 traditional-setting cases verified β†’ INCIDENTS=[]. HIV: ~12% adult (UNAIDS 2024); one of 15 VMMC priority countries; PHIA 2015-17: 15-34 significant (0.04% vs 0.34%, P=0.01); 35-59 reversed nonsignificant; combination prevention; no circ↔HIV causal claim. UNREGULATED β€” no male circ statute. FGM: STRICTLY SEPARATE. Filled: M1 (25% DHS 2013), M2 (HIV 12%), P1-P4, H1 (write-up), L1/L3/L4 (UNREGULATED), S1/S2 (8 graded sources #867-874), 5 claims, 0 incidents (honest gap). DEEP_BUILT.

Research claims

Short, testable claims backed by evidence and categorised for clarity.

View all claims
Prevalence High confidence High evidence

Namibia 21% (2006-07 DHS) β†’ 25.5% (2013); Otjozondjupa Region 72.27% (2017-18, medium conf)

Namibia's nationally representative male circumcision prevalence rose modestly from 21% (95% CI 19.7-22.3) in 2006-07 DHS (males, n=3,915; pre-VMMC baseline) to 25.5% (95% CI 24.2-26.9) in 2013 DHS. The 25.5% figure is corroborated by Morris 2016 (PMC4772313; erratum unchanged). The modest national increase likely understates post-VMMC uptake, since 52,022+ CDC-supported VMMCs were performed after 2013. At the regional level, the Otjozondjupa Region showed 72.27% overall circumcision prevalence (279/386 males, 2017-18 cross-sectional, MEDIUM confidence β€” convenience sample, 2-1 verified), with 66.66% traditionally circumcised and 33.34% medically circumcised. This regional figure substantially exceeds the national 25.5% average, consistent with high traditional circumcision in Otjozondjupa ethnic communities.

National DHS figures (21% and 25.5%) are 3-0 and 2-1 verified respectively. Otjozondjupa 72.27% is 2-1 verified, MODERATE confidence (convenience sample, not population-representative). The 21% figure with "one-quarter traditional" was refuted 0-3; Herero/Himba 55.56% was refuted 1-2 β€” both excluded.

Medical policy High confidence High evidence

Namibia VMMC 2017-2019: 52,022 CDC-supported procedures; 70.1-82.7% target; CDC transition β†’ zero CDC 2020-2021

Under CDC/PEPFAR support in 2017-2019, Namibia performed 52,022 total VMMCs: 15,579 in 2017 (70.1% target attainment), 19,384 in 2018 (82.7%), and 17,059 in 2019 (73.3%). Beginning in 2020, CDC support transitioned to another US government agency, resulting in zero CDC-reported procedures in 2020-2021. This transition makes post-2020 programme continuity and total procedure counts unavailable from the CDC MMWR primary source. Priority regions for the programme include Khomas (Windhoek) and Zambezi. Namibia is one of the 15 WHO/UNAIDS VMMC priority countries.

3-0 verified from CDC MMWR vol.72/10 (primary government source). Post-2020 Namibia VMMC data from the succeeding US agency is not available in this evidence base β€” an honest programme-continuity data gap.

Cultural practice Moderate confidence Moderate evidence

Namibia traditional circumcision: Owambo (OvaAmbo) practice documented; Otjozondjupa 66.66% traditional; ethnic variation

Owambo (OvaAmbo) people, comprising roughly 50% of Namibia's population and concentrated in northern regions (Oshana, Ohangwena, Omusati, Oshikoto), practice traditional male circumcision as a rite of passage. This is broadly documented in secondary and cultural sources; however, specific primary-sourced details for initiation ceremony terminology (ongombo/ombwiti), ages, duration, and secrecy practices did not survive adversarial verification β€” treat as background knowledge (medium confidence). The high traditional circumcision prevalence in Otjozondjupa Region (66.66% of circumcised males traditionally circumcised; 2017-18 cross-sectional) is contextually consistent with northern ethnic group practices in that region. Southern ethnic groups (Herero outside Otjozondjupa, Nama, Damara) have historically lower circumcision prevalence β€” the national 25.5% figure vs Otjozondjupa's 72.27% reflects this geographic and ethnic gradient.

MEDIUM confidence throughout: specific ongombo/ombwiti primary sources not verified. The Otjozondjupa 72.27% / 66.66% traditional figures are 2-1 verified (convenience sample). The Herero/Himba sub-claim (55.56% rate + "babies and small boys") was REFUTED 1-2 β€” excluded. Owambo traditional circumcision context is supported by secondary/cultural sources but not primary peer-reviewed ethnographic data for Namibia specifically.

HIV context High confidence High evidence

Namibia HIV ~12% adult (UNAIDS 2024) β€” VMMC priority; PHIA pooled context; no traditional harm cases verified

Namibia's adult HIV prevalence is approximately 12% (UNAIDS 2024). Namibia is one of the 15 WHO/UNAIDS VMMC priority countries. VMMC is one component of combination HIV prevention. Pooled PHIA data (2015-17, 8 sub-Saharan African countries including Namibia): statistically significant HIV incidence difference in medically circumcised vs uncircumcised men aged 15-34 (0.04% vs 0.34%, P=0.01); no protective association in 35-59 (reversed, nonsignificant). No circ↔HIV causal claim is made. No traditional-setting circumcision harm cases specifically attributed to Namibia appear in verified indexed medical literature β€” an honest evidence gap.

No circ↔HIV causal claim. PHIA pooled data limitations: self-reported circumcision status, heavy Tanzania weighting (39.4%), wide CIs. No Namibia-specific traditional harm case series confirmed β€” honest gap (not a claim of zero harm from traditional circumcision).

Complication High confidence High evidence

Namibia VMMC AE 1.7% (498/28,990; Oshana+Zambezi 2015-2018); infections/wound disruption 80%; early bleeding / late infection

In a peer-reviewed analysis of 28,990 VMMCs performed in Oshana and Zambezi regions (January 2015-August 2018), Namibia's VMMC programme recorded 498 moderate-or-severe adverse events β€” an overall AE rate of 1.7%. Severity breakdown: 77% moderate, 23% severe. AE type breakdown: infections and wound disruption accounted for 80% of all AEs; bleeding 8%; other (swelling, hematoma) 12%. By timing: bleeding predominated in early-onset events (on or before day 2); infections dominated late-onset events (after day 7). This real-world AE rate is within expected ranges for VMMC programmes in sub-Saharan Africa.

Data from two regions only (Oshana + Zambezi) β€” not nationally representative. 3-0 verified. The late-onset infection boundary is described as "after day 7" in the source; "days 3-14" framing would be imprecise.

Legal status

Unregulated

Namibia has no confirmed statute specifically regulating or prohibiting non-therapeutic male circumcision. The national VMMC programme operates as a public health implementation framework under PEPFAR/MoH support, not as legislation governing circumcision per se. FGM is a completely separate female issue and must never be conflated with any male circumcision practice in Namibia.

No Namibia statute specifically regulating, permitting, or prohibiting non-therapeutic male circumcision was confirmed in the verified research pass. The VMMC programme (previously CDC-supported, transitioned to another US agency in 2020) operates as a health system programme. Owambo traditional circumcision is legally unrestricted. FGM in Namibia is a separate female issue; any legal treatment of FGM has no bearing on male circumcision and must never be conflated with it. Some advocacy around restricting non-therapeutic infant circumcision has been noted in Namibia but no enacted statute was confirmed.

Medical & HIV context

12%

Adult HIV prevalence

UNAIDS (2024) Β· Adults 15–49

not-infant

Circumcision in newborns

Non-therapeutic (cultural practice)

TRADITIONAL: Owambo (OvaAmbo) people (~50% of Namibia's population, northern regions) practice male circumcision as a rite of passage β€” adolescent/teenage age range (background knowledge; specific initiation ceremony details [ongombo/ombwiti terms] not primary-sourced verified). Otjozondjupa Region: 72.27% overall circumcision (2017-18); 66.66% traditionally circumcised vs 33.34% medical. Non-circumcising: Herero, Nama/Damara in south and centre (background knowledge). VMMC: Khomas + Zambezi priority regions; CDC-supported procedures ended 2020 (transition to another US agency).

Typical age

Benchmarks are international context β€” not a local complication rate.

Incident registry

No verified incidents are currently recorded for Namibia.

This absence should not be read as proof that harm does not occur β€” only that no verified, sourced case has been documented in this database yet.

Country write-ups